Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

  1. Cohen, A.D.
  2. Mateos, M.-V.
  3. Cohen, Y.C.
  4. Rodriguez-Otero, P.
  5. Paiva, B.
  6. van de Donk, N.W.C.J.
  7. Martin, T.
  8. Suvannasankha, A.
  9. De Braganca, K.C.
  10. Corsale, C.
  11. Schecter, J.M.
  12. Varsos, H.
  13. Deraedt, W.
  14. Wang, L.
  15. Vogel, M.
  16. Roccia, T.
  17. Xu, X.
  18. Mistry, P.
  19. Zudaire, E.
  20. Akram, M.
  21. Nesheiwat, T.
  22. Pacaud, L.
  23. Avivi, I.
  24. San-Miguel, J.
Aldizkaria:
Blood

ISSN: 1528-0020,  0006-4971

Argitalpen urtea: 2023

Alea: 141

Zenbakia: 3

Orrialdeak: 219-230

Mota: Artikulua

DOI: 10.1182/BLOOD.2022015526 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus